⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL901230 | 1.00 | TP53 (0.57) | — | |
| SCHEMBL74607 | 1.00 | — | — | |
| SCHEMBL42054 | 1.00 | — | — | |
| Ammonia Solution, Strong SCHEMBL6545802 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL30716856 | 0.96 | — | — | |
| SCHEMBL29399187 | 0.96 | — | — | |
| Hydrogen Peroxide SCHEMBL11422902 | 0.96 | — | — | |
| Charcoal, Activated SCHEMBL12487647 | 0.96 | — | — | |
| Isopropyl Alcohol SCHEMBL16321076 | 0.96 | TP53 (0.53) | — | |
| Butanedione SCHEMBL2403188 | 0.92 | TSHR (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119744885-A | Application of Ace9 factor in enhancing activity of killing plant parasitic nematodes by using various bacillus | 华中农业大学 | 2025-04-04 | — | — | CN | claimed |
| CN-119111525-A | Liquid microbial agent containing small molecule microorganism-crop interaction signal substance and application thereof | 中化农业（临沂）研发中心有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-117660389-A | Transaminase mutant and application thereof in preparation of chiral amine compounds | 浙江容锐科技有限公司 | 2024-03-08 | — | — | CN | claimed |
| CN-107129959-A | Construction method and application of genetic engineering strain for producing (R) -acetoin | 广西科学院 | 2017-09-05 | — | — | CN | claimed |
| US-20260021148-A1 | METHODS FOR ENHANCING IMMUNE CHECKPOINT BLOCKADE THERAPY BY MODULATING THE MICROBIOME | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2026-01-22 | — | — | US | disclosed |
| WO-2025245512-A1 | METHODS TO SHIFT REDOX EQUILIBRIUM USING AN ORTHOGONAL REDOX COFACTOR, AND APPLICATIONS THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-11-27 | — | — | WO | disclosed |
| US-20250296907-A1 | METHOD FOR OBTAINING ACETOIN | LESAFFRE ET COMPAGNIE (FR) | 2025-09-25 | — | — | US | disclosed |
| EP-4567123-A2 | METHOD FOR PRODUCING L-AMINO ACID | AJINOMOTO CO., INC. (JP) | 2025-06-11 | — | — | EP | disclosed |
| US-12318413-B2 | Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-06-03 | — | — | US | disclosed |
| US-12310996-B2 | Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-05-27 | — | — | US | disclosed |
| CN-116254241-B | 2, 3-Butanediol dehydrogenase mutant and application thereof | 浙江大学杭州国际科创中心 | 2025-05-16 | — | — | CN | disclosed |
| CN-119744885-A | Application of Ace9 factor in enhancing activity of killing plant parasitic nematodes by using various bacillus | 华中农业大学 | 2025-04-04 | — | — | CN | disclosed |
| US-20080009435-A1 | Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them | PHARMA MAR, S.A., A SPAIN CORPORATION | 2008-01-10 | — | — | US | disclosed |
| WO-2007143745-A2 | SUBSTITUTED PHENYL ACETIC ACIDS AS DP-2 ANTAGONISTS | ICOS CORPORATION (US) | 2007-12-13 | — | — | WO | disclosed |
| US-20070244158-A1 | Piperdine Compound and Process for Preparing the Same | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-10-18 | — | — | US | disclosed |
| US-20070244158-A1 | Piperdine Compound and Process for Preparing the Same | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-10-18 | — | — | US | disclosed |
| US-20070238669-A1 | HUMAN GLUCAGON-LIKE-PEPTIDE-1 MODULATORS AND THEIR USE IN THE TREATMENT OF DIABETES RELATED CONDITIONS | BRISTOL-MYERS SQUIBB COMPANY | 2007-10-11 | — | — | US | disclosed |
| US-20070078146-A1 | Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma | PHARMACIA CORPORATION | 2007-04-05 | — | — | US | disclosed |
| US-20070043009-A1 | Quinazoline derivatives as tyrosine kinase inhibitors | ASTRAZENECA AB (SE) | 2007-02-22 | — | — | US | disclosed |
| WO-2006007700-A1 | HEPATITIS C INHIBITOR DIPEPTIDE ANALOGS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2006-01-26 | — | — | WO | disclosed |